There are 2 papers on MIR-130A-3P in aging research: 1 trial in people, 1 in animals.
2 papers study it1 finding
See all 2 papers on MIR-130A-3P
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Human trial1
- Animals1
Effects
1STAT3
downin mouse cells1
1 study
STAT3
downin mouse cells1
MIR-130A-3P inhibits STAT3 in mouse cells (binding to STAT3 mRNA 3'UTR).
“miR-130a-3p could negatively regulate STAT3 by binding to its mRNA 3'UTR”
Cellsbinding to STAT3 mRNA 3'UTR
Oxidative medicine and cellular longevity
Latest
Frontiers in Physiology
Physical Activity as a Preventive Lifestyle Intervention Acts Through Specific Exosomal miRNA Species-Evidence From Human Short- and Long-Term Pilot Studies
Non-randomized trial in 14 peopleInterventions
Oxidative Medicine and Cellular Longevity
Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway
Experiments in miceMetformin